Sensitive detection of glucagon aggregation using amyloid fibril‐specific antibodies
- 14 April 2019
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 116 (8) , 1868-1877
Abstract
Sensitive detection of protein aggregates is important for evaluating the quality of biopharmaceuticals and detecting misfolded proteins in several neurodegenerative diseases. However, it is challenging to detect extremely low concentrations (20 times more sensitive than detection using a conventional, amyloid‐specific fluorescent dye (Thioflavin T). We expect that this type of sensitive immunoassay can be readily integrated into the drug development process to improve the generation of safe and potent peptide therapeutics.Keywords
This publication has 39 references indexed in Scilit:
- A Novel, Stable, Aqueous Glucagon Formulation Using Ferulic Acid as an ExcipientJournal of Diabetes Science and Technology, 2014
- Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cellsMethods, 2012
- Mapping out the multistage fibrillation of glucagonThe FEBS Journal, 2011
- Optimization of the Native Glucagon Sequence for Medicinal PurposesJournal of Diabetes Science and Technology, 2010
- A Bihormonal Closed-Loop Artificial Pancreas for Type 1 DiabetesScience Translational Medicine, 2010
- Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 DiabetesDiabetes Care, 2010
- Amyloid Fibrils of Glucagon Characterized by High-Resolution Atomic Force MicroscopyBiophysical Journal, 2006
- AFM study of glucagon fibrillation via oligomeric structures resulting in interwoven fibrilsNanotechnology, 2006
- Protein misfolding, evolution and diseaseTrends in Biochemical Sciences, 1999
- Conformational states of glucagonBiochemical and Biophysical Research Communications, 1967